Breaking News

Galapagos Considers Winding Down Cell Therapy Business

Aims to improve efficiency and invest available cash in developing new therapeutics through strategic partnerships under new leadership.

Author Image

By: Charlie Sternberg

Associate Editor

Following a comprehensive review of strategic alternatives, including a potential divestiture, Galapagos NV has announced its intention to wind down its cell therapy business and pursue new transformational business development transactions with its available cash resources. The plan would enable the company to enhance operational efficiencies and focus on utilizing its available cash to execute its strategy of building a pipeline of novel therapeutics through strategic business development t...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters